Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-014943
Filing Date
2022-10-11
Accepted
2022-10-11 17:21:45
Documents
64
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q cydy-20220831x10q.htm   iXBRL 10-Q 1591190
2 EX-3.1 cydy-20220831xex3d1.htm EX-3.1 282478
3 EX-31.1 cydy-20220831xex31d1.htm EX-31.1 9269
4 EX-31.2 cydy-20220831xex31d2.htm EX-31.2 9438
5 EX-32 cydy-20220831xex32.htm EX-32 6384
6 GRAPHIC cydy-20220831xex3d1001.jpg GRAPHIC 3705
  Complete submission text file 0001558370-22-014943.txt   7458080

Data Files

Seq Description Document Type Size
7 EX-101.SCH cydy-20220831.xsd EX-101.SCH 64519
8 EX-101.CAL cydy-20220831_cal.xml EX-101.CAL 56280
9 EX-101.DEF cydy-20220831_def.xml EX-101.DEF 250319
10 EX-101.LAB cydy-20220831_lab.xml EX-101.LAB 418502
11 EX-101.PRE cydy-20220831_pre.xml EX-101.PRE 392915
58 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20220831x10q_htm.xml XML 1157123
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 221304826
SIC: 2834 Pharmaceutical Preparations